Animal Oversight Changes for Institutions Receiving National Aeronautics and Space Administration (NASA) Funding
On April 16, 2020, NIH and the National Aeronautics and Space Administration (NASA) announced a new agreement to ensure consistent and effective oversight of the welfare of animals used in NASA-funded activities. The agreement provides a framework to enhance communication and harmonize the agencies’ efforts while reducing regulatory burden to supported institutions. According to this agreement, institutions receiving NASA funding will need to: include NASA-supported activities with live vertebrate animals as covered activities in their PHS Animal Welfare Assurance (Assurance), andpromptly report situations involving...
Source: NIH Extramural Nexus - April 30, 2020 Category: Research Authors: NIH Staff Tags: Animal Welfare Top Stories laboratory animal OLAW Source Type: funding

Notice of Memorandum of Understanding Between NIH and NASA Concerning Laboratory Animal Welfare
Notice NOT-OD-20-095 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 16, 2020 Category: Research Source Type: funding

Supporting Tribal Public Health Capacity in Coronavirus Preparedness and Response
Non-competitive grants for Tribal governments and Tribal organizations to carry out public health emergency response activities in response to COVID-19. Activities may include surveillance, epidemiology, laboratory capacity, infection control, mitigation, communications, and other preparedness and response activities. Geographic coverage: Nationwide -- Centers for Disease Control and Prevention, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - April 6, 2020 Category: American Health Source Type: funding

Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-026 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to continue to provide operations support for Biosafety Level 4 (BSL4) facilities to the National Biocontainment Laboratories at the University of Texas Medical Branch (UTMB) in Galveston, Texas and Boston University in Boston, Massachusetts. Operations support is provided in the following areas: facility maintenance and operations; biosecurity; environmental health and safety regulations and requirements; regulatory compliance; and specialized research support services. The NBLs will...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 6, 2020 Category: Research Source Type: funding

Special Topic Research Education Course: Exploring Auditory and Vestibular Biology (R25 - Clinical Trial Not Allowed)
Funding Opportunity RFA-DC-20-001 from the NIH Guide for Grants and Contracts. The over-arching goal of this NIDCD R25 program is to support educational activities that foster a better understanding of biomedical research and its implications in the areas of auditory and vestibular research. The complexity of auditory and vestibular biology processes provide our hearing and balance function. Interruption of these processes may occur from a variety of factors, including genetic, environmental and pathogenic agents, and often results in the loss of hearing and balance function. While loss or impairment of these functions ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 23, 2020 Category: Research Source Type: funding

Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19
The NIH Office of Laboratory Animal Welfare (OLAW) is deeply concerned about the impact of the expanding outbreak of the respiratory illness, COVID-19, on the ability of Assured institutions to support the well-being of animals and personnel during this public health emergency. See NOT-OD-20-088 for flexibilities provided in the Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals (Policy) that are applicable to implementing a pandemic plan for animal care and use programs.  (Source: NIH Extramural Nexus)
Source: NIH Extramural Nexus - March 17, 2020 Category: Research Authors: NIH Staff Tags: Policy Top Stories Source Type: funding

NSF Innovation Corps Hubs Program (I-CorpsTM Hubs)
Full Proposal Deadline Date: April 14, 2020 Program Guidelines: NSF 20-529The National Science Foundation (NSF) seeks to further develop and nurture a national innovation ecosystem that guides the output of scientific discoveries closer to the development of technologies, products, and services that benefit society. The goal of the NSF Innovation Corps (I-Corps) Program, created in 2011 by NSF, has been and will continue to be to reduce the time and risk associated with translating promising ideas and technologies from the laboratory to the ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505760&WT.mc_id=USNSF_3...
Source: NSF Upcoming Due Dates - March 15, 2020 Category: Science Source Type: funding

Rural Experiences for Health Professions Students Summer Experience Program
A program that places clinical psychology, master of social work, physician, physician assistant, medical laboratory science, nurse practitioner, pharmacy, nursing, physical and occupational therapy students from South Dakota in a 4-week experience with preceptors established in rural or frontier areas of South Dakota. Geographic coverage: South Dakota -- Yankton Rural Area Health Education Center (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - March 2, 2020 Category: American Health Source Type: funding

Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (R35 - Clinical Trial Optional)
Funding Opportunity PAR-20-117 from the NIH Guide for Grants and Contracts. The Maximizing Investigators' Research Award (MIRA) under this FOA is a grant to provide support for a program of research in an early stage investigator's laboratory that falls within the mission of NIGMS. For the purpose of this FOA, a program of research is a collection of projects in the investigator's lab that are relevant to the mission of NIGMS. The goal of MIRA is to increase the efficiency and efficacy of NIGMS funding. It is anticipated that this FOA will: Enable investigators to apply earlier in their independent research careers, all...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 24, 2020 Category: Research Source Type: funding

Notice of Special Interest (NOSI): Administrative Supplements to Enhance Laboratory Safety Curriculum and a Culture of Safety in Biomedical Research Training Environments
Notice NOT-GM-20-016 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 13, 2020 Category: Research Source Type: funding

Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed)
Funding Opportunity RFA-OD-20-002 from the NIH Guide for Grants and Contracts. This FOA encourages grant applications for national Animal and Biological Material Resource Centers. These Centers provide support for special colonies of laboratory animals, as well as other resources such as informatics tools, reagents, cultures (cells, tissues, and organs) and genetic stocks that serve the biomedical research community in a variety of research areas on a local, regional, and national basis. The important mission of the projects described by this FOA is to provide research resources, which are facilitating the optimization ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 8, 2020 Category: Research Source Type: funding

Mechanisms of Rejuvenation and Age-Acceleration in Heterochronic Blood Exchange (R01 Clinical Trial Not Allowed)
The objectives are to identify the multiple factors involved, the multiple cell types involved and the mechanisms underlying rejuvenation or accelerated aging that is observed in the transfer of phenotypes between young and old laboratory animals. It is also anticipated that molecular signatures of rejuvenation or accelerated aging will be obtained from research supported under this FOA. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 17, 2019 Category: Research Source Type: funding

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-074 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the pace of translation of NCI-supported methods/assays/technologies (referred to as "assays") to the clinic. Specifically, the focus of this FOA is on the adaption and clinical validation of molecular/cellular/imaging markers (referred to as "markers" r "biomarkers") for cancer detection, diagnosis, prognosis, monitoring, and prediction of response in treatment, as well as markers for cancer control and prevention. Research applications may support the acquisition of we...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 10, 2019 Category: Research Source Type: funding

National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 Clinical Trial Optional)
Funding Opportunity RFA-HD-21-012 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to announce the re-competition of the National Centers for Translational Research in Reproduction and Infertility (NCTRI). The NCTRI will be administered through the Specialized Research Center (P50) award mechanism. These centers will form a national network that facilitates and accelerates bidirectional knowledge transfer between the laboratory and clinic with the ultimate goal of improving human reproductive health through research excellence and innovation. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 4, 2019 Category: Research Source Type: funding

New Approaches for Incorporating Genetic Diversity into Toxicity Testing (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-20-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports Phase I (R43), Direct to Phase II (R44), and Fast Track (R44) Small Business Innovative Research (SBIR) grant proposals from small businesses concerns (SBCs) to develop resources and approaches, including panels of cells or model organisms, that can better reflect the variability in human populations in chemical toxicity testing. Current toxicology testing is often limited to studies conducted in a small number of laboratory rodent strains, which can fail to identify clinically relevant tox...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 27, 2019 Category: Research Source Type: funding